Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study

Arthritis and Rheumatism
M L HetlandCIMESTRA study group

Abstract

To investigate whether disease control can be achieved in early active rheumatoid arthritis (RA) by treatment with methotrexate and intraarticular betamethasone, and whether the addition of cyclosporine to the regimen has any additional effect. Patients (n = 160) were randomized to receive methotrexate 7.5 mg/week plus cyclosporine 2.5 mg/kg of body weight/day (combination therapy) or methotrexate plus placebo-cyclosporine (monotherapy). At weeks 0, 2, 4, 6, and 8 and every 4 weeks thereafter, betamethasone was injected into swollen joints (maximum 4 joints or 4 ml per visit). Beginning at week 8, if synovitis was present, the methotrexate dosage was increased stepwise up to 20 mg/week, with a subsequent stepwise increase in the cyclosporine or placebo-cyclosporine dosage up to 4 mg/kg. At 52 weeks, 20% improvement according to the American College of Rheumatology criteria (ACR20) was achieved in 85% of the combination therapy group versus 68% of the monotherapy group (P = 0.02). The median individual overall ACR response (ACR-N) in the 2 groups was 80.0% (interquartile range 40.1-91.8%) and 54.5% (interquartile range 2.4-87.8%), respectively (P = 0.025). At 48 and 52 weeks, ACR remission criteria were met in 35% of the combina...Continue Reading

References

Mar 28, 1985·The New England Journal of Medicine·M E WeinblattD E Trentham
Oct 1, 1981·Arthritis and Rheumatism·R S PinalsR A Larsen
Jun 1, 1996·Arthritis and Rheumatism·G PaseroO Della Casa-Alberighi
Nov 30, 2000·The New England Journal of Medicine·J M BathonB K Finck
Feb 13, 2002·Arthritis and Rheumatism·UNKNOWN American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines
Nov 6, 2004·Arthritis and Rheumatism·E William St ClairUNKNOWN Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset Study Grou

❮ Previous
Next ❯

Citations

Sep 6, 2012·Rheumatology International·Kresten Krarup KellerEllen-Margrethe Hauge
Jan 27, 2011·Zeitschrift für Rheumatologie·K Krüger
Oct 8, 2011·Zeitschrift für Rheumatologie·K Krüger, K Karberg
Dec 10, 2013·Best Practice & Research. Clinical Rheumatology·Marjatta Leirisalo-Repo
Jun 19, 2013·Molecular and Cellular Endocrinology·Ulrike BaschantJan Tuckermann
Aug 1, 2007·Nature Clinical Practice. Rheumatology·W Neal Roberts
Oct 10, 2012·Nature Reviews. Rheumatology·Ulrike BaschantJan Tuckermann
Apr 30, 2009·Rheumatology·Patrick D W KielyPhilip G Conaghan
Apr 7, 2007·Current Opinion in Rheumatology·Kate L Mitchell, David S Pisetsky
Apr 7, 2007·Current Opinion in Rheumatology·Eric F Morand
Apr 7, 2007·Current Opinion in Rheumatology·Kanako Kitahara, Shinichi Kawai
Apr 15, 2008·Annals of the Rheumatic Diseases·David T FelsonJeffrey N Siegel
Mar 12, 2013·Clinical Medicine : Journal of the Royal College of Physicians of London·Nicola TugnetRavinder Sandhu
Sep 4, 2013·Immunotherapy·Florian M P MeierUlf Müller-Ladner
Feb 6, 2010·Scandinavian Journal of Rheumatology·A de ThurahK Stengaard-Pedersen
Mar 7, 2008·Expert Opinion on Emerging Drugs·Paraskevi V Voulgari
Jan 15, 2016·Nature Reviews. Rheumatology·Ronald van Vollenhoven
Feb 29, 2008·Journal of Pharmaceutical Sciences·Claus LarsenPia H Andersen
Jan 24, 2012·Best Practice & Research. Clinical Rheumatology·Per QvistMorten A Karsdal
Dec 6, 2011·Best Practice & Research. Clinical Rheumatology·M S JurgensJ W J Bijlsma
Feb 8, 2011·Seminars in Arthritis and Rheumatism·Boulos Haraoui, Janet Pope
Nov 2, 2014·Arthritis Research & Therapy·Christian Gytz AmmitzbøllKristian Stengaard-Pedersen
Jun 10, 2008·British Journal of Clinical Pharmacology·Lyudmila Sizova
Feb 19, 2014·Annals of the Rheumatic Diseases·Jan SørensenUNKNOWN all departments of rheumatology in Denmark
Feb 24, 2009·Best Practice & Research. Clinical Rheumatology·David L Scott
Oct 15, 2013·Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology·Chuanxia LiuHongmei Zhou
Aug 16, 2016·Clinical Reviews in Allergy & Immunology·Cecilia Beatrice ChighizolaPier Luigi Meroni
Aug 20, 2016·BMC Musculoskeletal Disorders·Jeroen P JansenGene V Wallenstein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.